Sodium Balance and Symptomatic Vasospasm in Patients with Subarachnoid Hemorrhage
نویسنده
چکیده
Hyponatremia is a common complication after subarachnoid hemorrhage. Although the mechanism of hyponatremia is still controversial, cerebral salt wasting syndrome is currently more favored over the the syndrome of inappropriate secretion of antidiuretic hormone. To accurately manage body water and electrolytes in the acute stage of subarachnoid hemorrhage, we prospectively studied the relations among the daily sodium balance, serum sodium, central venous pressure, and body weight. Ten of 30 patients demonstrated hyponatremia (serum sodium <135 mEq/L) during day 7 to 9 after subarachnoid hemorrhage. In these 10 patients hyponatremia was always preceded by a negative sodium balance, a decrease in central venous pressure and a decrease in body weight. Symptomatic vasospasm was coincident with hyponatremia in two patients. In 13 of the 20 patients who did not develop hyponatremia, we found a negative sodium balance; its duration was significantly shorter than with patients with hyponatremia. These findings indicate that natriuresis develops within the first week after subarachnoid hemorrhage: and when a negative sodium balance due to natriuresis lasts several days, hyponatremia with dehydration develops at the second week. These factors increase the risk of symptomatic vasospasm. We conclude that a greater replacement of water and sodium is required to maintain "normovolemia" within the first week after subarachnoid hemorrhage. This fluid replacement protocol may be helpful for the prevention of vasospasm following subarachnoid hemorrhage.
منابع مشابه
Comparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage
Cerebral vasospasm considered to be a serious cause of morbidity and mortality following subarachnoid haemorrhage (SAH).Despite several available therapeutic options, current protocols do not prevent major consequences of vasospasm. Inflammation is believed to play an important role in post-haemorrhagic vasospasm. Meloxicam is a non-steroidal anti-inflammatory drug. The aim of this study was to...
متن کاملComparative Efficacy of Meloxicam and Placebo in Vasospasm of Patients with Subarachnoid Hemorrhage
Cerebral vasospasm considered to be a serious cause of morbidity and mortality following subarachnoid haemorrhage (SAH).Despite several available therapeutic options, current protocols do not prevent major consequences of vasospasm. Inflammation is believed to play an important role in post-haemorrhagic vasospasm. Meloxicam is a non-steroidal anti-inflammatory drug. The aim of this study was to...
متن کاملCombination therapy of fasudil hydrochloride and ozagrel sodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Fasudil hydrochloride is a new type of intracellular calcium antagonist, different from the calcium entry blockers that are commonly employed for clinical use. Since September 1995, the combination of fasudil hydrochloride and ozagrel sodium, an inhibitor of thromboxane A2 synthesis, has been used to treat 60 patients at risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. The e...
متن کاملCORRELATION BE TWEEN ENDOTHELIAL INJURY AND CEREBRAL VASOSPASM FOLLOWING A DOUBLE SUBARACHNOID HEMORRHAGE IN THE RAT
While a wide array of pathological changes occur in cerebral arteries following subarachnoid hemorrhage (SAH), the most consistent is endothelial damage. Since the endothelium normally modulates reflexes that influence vascular tone, any damage to it may represent a significant contributor to cerebral vasospasm following SAH. This experimental study investigates the correlation between end...
متن کاملCorrelation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients.
Serial changes in platelet and white blood cell (WBC) counts and other blood parameters were analyzed in 103 patients with aneurysmal subarachnoid hemorrhage (SAH). The WBC counts during days 3-5, 6-8, 9-11, and 12-14 after the onset of SAH were significantly higher in patients with than in patients without symptomatic vasospasm. Platelet counts during days 0-2, 3-5, 6-8, 9-11, 12-14, 15-17, 18...
متن کامل